Anvisa updates the Reference Medicines List.
The National Health Surveillance Agency (ANVISA) has updated the Reference Drug List, which classifies medications into groups based on their composition.
European Shortages Monitoring Platform: A New Era in Medicine Management
The European Shortage Monitoring Platform (ESMP), launched on January 29, 2025, enhances the monitoring and management of medicine shortages across the EU. It enables quicker responses and better crisis management in drug unavailability situations.
FDA Proposes New Front-of-Package Nutrition Label to Help Consumers Make Healthier Choices
FDA proposes a new front-of-package nutrition label to help consumers make healthier food choices, focusing on key nutrients like saturated fat, sodium, and added sugars, promoting better public health.
APMC Conducts Innovative Study on Medicinal Cannabis for Osteoporosis and Chronic Pain in Women
The Pan American Association of Cannabinoid Medicine (APMC) is leading an innovative study on the use of medicinal cannabis in the treatment of osteoporosis and chronic pain in women. The research investigates bone biomarkers and genetic polymorphisms to personalize therapies and expand access to treatment within the SUS.
FDA Proposes New Front-of-Package Nutrition Label to Help Consumers Make Healthier Choices
FDA proposes a new front-of-package nutrition label to help consumers make healthier food choices, focusing on key nutrients like saturated fat, sodium, and added sugars, promoting better public health.
APMC Conducts Innovative Study on Medicinal Cannabis for Osteoporosis and Chronic Pain in Women
The European Commission has launched a public consultation on medical device regulations. Participate by March 21, 2025, and contribute to their evaluation.
European Commission Launches Public Consultation on Medical Devices and In Vitro Diagnostics Regulations
The European Commission has launched a public consultation on medical device regulations. Participate by March 21, 2025, and contribute to their evaluation.
Resolution No. 954: Changes to Drug Registration Take Effect
What changes with Anvisa Resolution No. 954? The new regulation, set to take effect on January 21, 2025, introduces adjustments to drug registration, post-registration, and renewal processes, enhancing transparency and sanitary control.
FDA issues preliminary guidance for medical devices with Artificial Intelligence
First Guidance to Provide Comprehensive Recommendations for Artificial Intelligence in Medical Devices for Developers
EU Regulation 2021/2282 on Health Technology Assessment Enters into Force
As of January 12, the EU regulation comes into effect to facilitate access to innovative medicines and medical devices, with INFARMED actively contributing to its implementation.
